Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › GenMark Diagnostics Reports 64 Percent Rise in Q2 Revenues

GenMark Diagnostics Reports 64 Percent Rise in Q2 Revenues

Jul 28, 2016
|
staff reporter

NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Thursday that its second quarter revenues rose 64 percent, driven by strength in sales of its XT-8 eSensor molecular diagnostics system and its infectious disease menu.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Molecular Diagnostics

  1. FDA Fleshes Out Emergency Guidance for Coronavirus Test Developers

  2. Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

  3. Luminex Receives FDA Emergency Use Authorization for Coronavirus Multiplex Panel

  4. BGI Americas Gets US Emergency Use Authorization for Coronavirus Test

  5. BioMérieux Rapid Coronavirus Test Gets FDA Emergency Use Authorization

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.